---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-068189"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T18:28:36.185268+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma sets Jan 30, 2024 annual meeting, Dec 6 record date, Dec 11 proposal deadline

## Summary
- Annual meeting scheduled for January 30, 2024; record date for voting is December 6, 2023.
- Shareholder proposals or director nominations must be received by December 11, 2023.
- Proxy materials expected to be available beginning on or about December 19, 2023.

## SEC filing metadata
- accession: 0000950170-23-068189
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/0000950170-23-068189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/abio-20231204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-068189
- JSON: https://secwatch.observer/filing/0000950170-23-068189.json
- Plain text: https://secwatch.observer/filing/0000950170-23-068189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.